GOLDMAN SACHS GROUP INC - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$26,599
+349.6%
28,598
+69.2%
0.00%
Q4 2022$5,916
-34.3%
16,902
-1.9%
0.00%
Q3 2022$9,000
-35.7%
17,227
+1.2%
0.00%
Q2 2022$14,000
-36.4%
17,030
+12.4%
0.00%
Q1 2022$22,000
-85.7%
15,157
-72.7%
0.00%
Q4 2021$154,000
-43.0%
55,526
+16.0%
0.00%
Q3 2021$270,000
-25.0%
47,860
+42.6%
0.00%
Q2 2021$360,000
-18.0%
33,552
+70.8%
0.00%
Q1 2021$439,000
-73.9%
19,649
-43.9%
0.00%
Q4 2020$1,681,00035,0000.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders